We are live on
!
Find out more
BFA
BlackRock Fund Advisors Portfolio holdings
AUM
$542B
1-Year Est. Return
18.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417B
AUM Growth
-$1.66B
(-0.4%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
9.45%
Holding
4,011
New
140
Increased
1,618
Reduced
1,966
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Germany ETF
EWG
|
+$739M |
| 2 |
iShare MSCI Eurozone ETF
EZU
|
+$723M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$662M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$452M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$553M |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$381M |
| 3 |
Qorvo
QRVO
|
+$377M |
| 4 |
TEG
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
|
+$319M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.1% |
| 2 | Financials | 12.85% |
| 3 | Technology | 12.68% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
3151
DELISTED
KalVista Pharmaceuticals
KALV
| $2.33M | ﹤0.01% |
+23,296
| New | +$2.31M |
|
3152
Hallador Energy
HNRG
$646M
| $2.31M | ﹤0.01% |
277,190
-2,234
| -0.8% | -$22.6K |
|
3153
TIM SA
TIMB
$9.1B
| $2.27M | ﹤0.01% |
138,860
+14,310
| +11% | +$228K |
|
|
IRS
3154
IRSA Inversiones y Representaciones
IRS
$1.31B
| $2.26M | ﹤0.01% |
+130,491
| New | +$2.34M |
|
|
NADL
3155
DELISTED
North Atlantic Drilling Ltd
NADL
| $2.25M | ﹤0.01% |
189,138
+7,239
| +4% | +$102K |
|
|
ERF
3156
DELISTED
Enerplus Corporation
ERF
| $2.22M | ﹤0.01% |
252,602
+284
| +0.1% | +$3.03K |
|
|
AINC
3157
DELISTED
Ashford Inc.
AINC
| $2.21M | ﹤0.01% |
25,368
+5,708
| +29% | +$556K |
|
|
JMI
3158
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $2.16M | ﹤0.01% |
302,874
-31,038
| -9% | -$236K |
|
3159
Travelzoo
TZOO
$76.7M
| $2.11M | ﹤0.01% |
187,310
-22,121
| -11% | -$268K |
|
|
CVRS
3160
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $2.1M | ﹤0.01% |
+597,348
| New | +$2.55M |
|
|
NYNY
3161
DELISTED
Empire Resorts, Inc.
NYNY
| $2.1M | ﹤0.01% |
82,399
-48
| -0.1% | -$1.24K |
|
|
MDLY
3162
DELISTED
Medley Management Inc
MDLY
| $2.08M | ﹤0.01% |
17,594
-285
| -2% | -$33K |
|
|
NTLS
3163
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $2.06M | ﹤0.01% |
446,612
-20,031
| -4% | -$127K |
|
3164
CGI
GIB
$15.6B
| $2.04M | ﹤0.01% |
52,221
+1,346
| +3% | +$58K |
|
|
ELP
3165
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $1.99M | ﹤0.01% |
451,713
+55,953
| +14% | +$249K |
|
|
CALA
3166
DELISTED
Calithera Biosciences, Inc
CALA
| $1.96M | ﹤0.01% |
+13,694
| New | +$3.17M |
|
3167
Canadian Solar
CSIQ
$932M
| $1.93M | ﹤0.01% |
67,579
+8,623
| +15% | +$296K |
|
3168
XBiotech
XBIT
$68.6M
| $1.91M | ﹤0.01% |
+105,770
| New | +$2.19M |
|
|
CNXR
3169
DELISTED
Connecture, Inc.
CNXR
| $1.9M | ﹤0.01% |
179,748
-2,989
| -2% | -$33K |
|
|
TSL
3170
DELISTED
Trina Solar Limited
TSL
| $1.85M | ﹤0.01% |
158,633
+22,225
| +16% | +$275K |
|
|
FWM
3171
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $1.84M | ﹤0.01% |
517,436
-14,178
| -3% | -$70.6K |
|
|
XBKS
3172
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $1.8M | ﹤0.01% |
86,722
-5,177
| -6% | -$98K |
|
|
CDTX
3173
DELISTED
Cidara Therapeutics
CDTX
| $1.8M | ﹤0.01% |
+6,407
| New | +$1.97M |
|
|
NGD
3174
DELISTED
New Gold Inc
NGD
| $1.76M | ﹤0.01% |
653,631
-39,112
| -6% | -$128K |
|
|
MPX
3175
DELISTED
Marine Products Corp
MPX
| $1.75M | ﹤0.01% |
280,372
-7,927
| -3% | -$56.7K |
|
Similar funds
BIT
BG
BA
BIM
BJ
IC
EAM
MFS
BlackRock Fund Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, BlackRock Fund Advisors held 4,011 positions worth $417B, down 0.4% from $419B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
BlackRock Fund Advisors's Q2 2015 filing shows 140 new, 1,618 increased, 1,966 reduced and 139 closed positions. Its largest new stake was Jazz Pharmaceuticals: 1,516,810 shares worth $267M. The largest sale was LORILLARD INC COM STK, an estimated $553M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- BlackRock Fund Advisors's largest Q2 2015 buy was Jazz Pharmaceuticals: 1,516,810 shares worth $267M.
- BlackRock Fund Advisors added most to iShares MSCI Germany ETF in Q2 2015, an estimated $739M increase.
- BlackRock Fund Advisors's biggest Q2 2015 reduction was Qorvo, cutting an estimated $377M.
- BlackRock Fund Advisors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $553M.
- BlackRock Fund Advisors's ten largest holdings make up 9.5% of its $417B portfolio in Q2 2015.
- BlackRock Fund Advisors opened 140 new positions and closed 139 in Q2 2015.
- BlackRock Fund Advisors's portfolio value fell 0.4% quarter-over-quarter to $417B.
Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.